Keywords: Grunenthal, Financial results, First-half 2012

Grunenthal sees core business sales grow 9% as EBITA leaps 147%

Article | 13 September 2012

German family-owned drugmaker Grunenthal reported first-half 2012 revenues of 473 million euros ($597.6 million), a dip of 2.1% on the 483 million euros achieved in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Grunenthal

Go to company listing